11 Aug 2016

“Our new branding – highlighted by a new logo – represents how BioPlus continues to innovate.”

BioPlus Specialty Pharmacy Announces Rebranding and Unveils a New Logo

One of the nation’s leading innovative specialty pharmacies, BioPlus Specialty Pharmacy, signals company evolution with rebranding, including the launch of a new logo.

 

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, announces today a rebranding, which includes a new look and logo. The new logo, representing the evolution of the company, now has a vibrant green replacing the previous blue in the logo. This color change signals the company’s commitment to vibrancy, growth, and an ongoing willingness to respond to the changing needs of the marketplace.

“Our new branding – highlighted by a new logo – represents how BioPlus continues to innovate,” shares Stephen Vogt, Pharm.D., President and CEO of BioPlus. “Our revamped look celebrates both our past and our future. As a health care company, we will continue to provide individualized pharmaceutical care for our patients and partner with prescribers and payers, but the new vibrant green color represents our ongoing commitment to meeting the needs of a changing field. We are not a stagnant company, we are growing and changing to meet new needs,” he adds.

What will not change with this rebranding is how BioPlus continues to use innovation: making it easy to refer a patient, fast to start on the prescribed therapy, and ensures a proven outcome. All three of these areas contribute to BioPlus creating a meaningful difference to our patients, prescribers, payers, and pharmaceutical partners.

BioPlus offers an industry-leading HCV Treatment App for hepatitis C that was the first of its kind. Not only is this guide easy to use, but it notifies prescribers of changes made by the FDA and the AASLD, based on emerging information, to current HCV treatment. In oncology, our 2-Hour Patient Acceptance Guarantee continues to be well-received by both prescribers and patients, who appreciate our quick response to critical, time-sensitive treatments. This guarantee would not be possible without our commitment to new technology and processes.

“Our new logo and color say: ‘We are Big, Bold, And Beyond HCV.’ BioPlus holds a commitment as a team to take the things that made us a leading, independent specialty pharmacy in hepatitis C and translate them so that we will be the leading independent in other critical pharmaceutical care areas,” says Dr. Vogt.

Today, BioPlus is a top 10 specialty pharmacy serving the specialty pharmacy needs of patients with hepatitis C, cancer, multiple sclerosis, bleeding disorders, and other complex chronic health conditions, along with building strong relationships with prescribers, payers, and the pharmaceutical industry.

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is the first specialty pharmacy to introduce a two-hour turnaround from referral to patient acceptance. BioPlus… Where healing begins in 2 hours. Our company celebrates 27 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. Our proprietary web tool Tap App connects prescribers to the pharmacy by bringing the pharmacy chart into the doctor’s office with real-time specialty pharmacy information and treatment monitoring.

BioPlus provides a complete range of specialty services, including for hepatitis C, multiple sclerosis, cancer, bleeding disorders, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and the Accreditation Commission for Health Care (ACHC).

For information: http://www.bioplusrx.com or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744

20 Jul 2016

BioPlus Specialty Pharmacy Pledges Support to OneOrlando Fund

One of the nation’s leading innovative specialty pharmacies, BioPlus Specialty Pharmacy, adapts its Pay It Forward charitable program to channel contributions directly to OneOrlando Fund in support of The Pulse tragedy victims and their families.

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, announces the adaptation of the charitable Pay It Forward program to provide specific support to the OneOrlando Fund. During the month of July, BioPlus will increase the company’s donations to Pay It Forward, earmarking the higher level of donations directly to OneOrlando in order to support the victims and their families of The Pulse tragedy.

The OneOrlando Fund was formed by the City of Orlando and announced by Orlando’s Mayor Buddy Dyer in the wake of the shooting tragedy at The Pulse. This fund provides support to the victims and their families affected by the deadly attack.

Pay It Forward, since its inception in 2013, has provided $180,000 in donations to multiple non-profit patient foundations. The Pay It Forward campaign, by partnering with BioPlus’ 2-Hour Patient Acceptance Guarantee, makes a donation to a non-profit patient foundation for every referral received at BioPlus. During the month of July, BioPlus will increase the donation for every referral by $1, with that money going directly to OneOrlando.

“Our hearts break for the victims of this senseless tragedy and we want to reach out with love and support to those affected,” says Barbara Weller, Senior Vice President of Finance at BioPlus. “As a health care company based in the Orlando area, we felt drawn to help those in our community, as well as put action behind our words of condolences for all who were affected – the victims, their families, their friends, and all their loved ones. BioPlus stands with you and supports you.”

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is the first specialty pharmacy to introduce a two-hour turnaround from referral to patient acceptance. BioPlus… Where healing begins in 2 hours. Our company celebrates 27 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. Our proprietary web tool Tap App connects prescribers to the pharmacy by bringing the pharmacy chart into the doctor’s office with real-time specialty pharmacy information and treatment monitoring.

BioPlus provides a complete range of specialty services, including for hepatitis C, multiple sclerosis, cancer, bleeding disorders, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and the Accreditation Commission for Health Care (ACHC).

For information: http://www.bioplusrx.com or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744

###

20 Jul 2016

“As we work with prescribers, we’ve found even more ways that we can improve the performance and functionality of the application in ways that are relevant to the user experience."

BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App Version 4.0, Including Guidelines for the Latest Hepatitis C Medication

One of the nation’s leading innovative specialty pharmacies, BioPlus Specialty Pharmacy, announces an updated and expanded version of a prescriber app to guide the decision process for hepatitis C therapy.

 

hcv app iphone
HCV Treatment Path

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, announces the release of ‘HCV Treatment Path’ app version 4.0. This revamped version brings an enhanced interface to improve the ease of use on mobile devices, as well as guidelines on all the hepatitis C medications including even the latest: Epclusa® (sofosbuvir/velpatasvir) from Gilead that was approved by the FDA on June 28, 2016.

This updated edition of the HCV Treatment Path app, designed to be used by prescribers, provides the latest therapy guidelines for treating chronic hepatitis C virus (HCV) infections. The app offers prescribers and other users additional features and the most up-to-date content. There are numerous medications that a prescriber could select for each individual case. This app offers guidelines and tools to streamline the selection of treatment that is best-suited to individual patients, based on criteria from experts such as the FDA and the AASLD (American Association for the Study of Liver Diseases). The HCV Treatment Path app, which earned a 5-star rating from iTunes, has already been downloaded for use by 3,100 prescribers.

“It’s exciting to get this latest version of our HCV Treatment Path app into prescribers’ hands to aid in the process of navigating the ever-changing HCV treatment landscape,” shares Elvin Montanez, Pharm.D., Chief Operations Officer at BioPlus. “As we work with prescribers, we’ve found even more ways that we can improve the performance and functionality of the application in ways that are relevant to the user experience,” Dr. Montanez adds.

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is the first specialty pharmacy to introduce a two-hour turnaround from referral to patient acceptance. BioPlus… Where healing begins in 2 hours. Our company celebrates 27 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. Our proprietary web tool Tap App connects prescribers to the pharmacy by bringing the pharmacy chart into the doctor’s office with real-time specialty pharmacy information and treatment monitoring.

BioPlus provides a complete range of specialty services, including for hepatitis C, multiple sclerosis, cancer, bleeding disorders, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and the Accreditation Commission for Health Care (ACHC).

For information: http://www.bioplusrx.com or
Contact: info(at)bioplusrx.com
Phone: 1-888-292-0744

###

20 Jul 2016

“There are six genotypes of the hepatitis C virus. Prior hepatitis C medications generally only treated one or a few of these genotypes. One of the exciting things for prescribers and patients about Epclusa is that it’s approved to treat all six genotypes."

BioPlus Specialty Pharmacy Now Dispensing New Hepatitis C One-Pill Combination: Epclusa

One of the nation’s leading innovative specialty pharmacies, BioPlus Specialty Pharmacy, is providing the newly approved combination Epclusa® (sofosbuvir/velpatasvir) to treat all genotypes of hepatitis C.

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, announces it is now dispensing Epclusa® (sofosbuvir/velpatasvir). Epclusa, a one-pill, once daily combination of Sovaldi® (sofosbuvir) with a new NS5A inhibitor called velpatasvir manufactured by Gilead, was approved by the U.S. Food and Drug Administration on June 28, 2016 after a priority review of its New Drug Application. It is approved to treat adult patients with hepatitis C, both with and without cirrhosis.

Epclusa’s approval was supported by a series of four clinical trials demonstrating excellent safety and efficacy during 12-week treatment courses. Two of these studies indicated a 97-100% cure rate (measured by sustained virologic response) in patients with genotypes 1a, 1b, 2, 4, 5, or 6. Patients with the difficult-to-treat genotype 3 reached 95% sustained virologic response. Genotype 3 accounts for about 20% of hepatitis C cases in the U.S. Patients with cirrhosis or previous treatment failure were found to achieve sustained virologic responses of 89-91%. Few serious adverse effects were noted (16-19%), generally headache and fatigue.

“There are six genotypes of the hepatitis C virus. Prior hepatitis C medications generally only treated one or a few of these genotypes. One of the exciting things for prescribers and patients about Epclusa is that it’s approved to treat all six genotypes,” says Sharon Ferrer, VP of Pharmaceutical Relations at BioPlus. “In addition, the low cost (wholesale acquisition cost of $74,760) comes in at nearly 50% lower than previous treatments available for the difficult-to-treat genotype 3 of hepatitis C virus.”

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is the first specialty pharmacy to introduce a two-hour turnaround from referral to patient acceptance. BioPlus… Where healing begins in 2 hours. Our company celebrates 27 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. Our proprietary web tool Tap App connects prescribers to the pharmacy by bringing the pharmacy chart into the doctor’s office with real-time specialty pharmacy information and treatment monitoring.

BioPlus provides a complete range of specialty services, including for hepatitis C, multiple sclerosis, cancer, bleeding disorders, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and the Accreditation Commission for Health Care (ACHC).

For information: http://www.bioplusrx.com or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744

###